These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28165818)

  • 21. Development of Itraconazole Liquisolid Compact: Effect of Polyvinylpyrrolidone on the Dissolution Properties.
    Gong W; Wang Y; Sun L; Yang J; Shan L; Yang M; Gao C
    Curr Drug Deliv; 2016; 13(3):452-61. PubMed ID: 26882116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of liquisolid technology for enhancing solubility and dissolution of rosuvastatin.
    Kamble PR; Shaikh KS; Chaudhari PD
    Adv Pharm Bull; 2014; 4(2):197-204. PubMed ID: 24511485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liquisolid Technique: A Novel Technique with Remarkable Applications in Pharmaceutics.
    Singh S; Singh J; Arora D
    Curr Drug Discov Technol; 2024; 21(1):e101023222025. PubMed ID: 38629170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acyclovir-Polyethylene Glycol 6000 Binary Dispersions: Mechanistic Insights.
    Venkateskumar K; Parasuraman S; Gunasunderi R; Sureshkumar K; Nayak MM; Shah SAA; Khoo K; Kai HW
    AAPS PharmSciTech; 2017 Aug; 18(6):2085-2094. PubMed ID: 28004342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liquisolid technique as a tool for enhancement of poorly water-soluble drugs and evaluation of their physicochemical properties.
    Javadzadeh Y; Siahi MR; Asnaashari S; Nokhodchi A
    Acta Pharm; 2007 Mar; 57(1):99-109. PubMed ID: 19839410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidine.
    Jantratid E; Prakongpan S; Amidon GL; Dressman JB
    Clin Pharmacokinet; 2006; 45(4):385-99. PubMed ID: 16584285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effervescent tablet formulation for enhanced patient compliance and the therapeutic effect of risperidone.
    Mohammed KA; Ibrahim HK; Ghorab MM
    Drug Deliv; 2016; 23(1):297-306. PubMed ID: 24833273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro release evaluation of hydrocortisone liquisolid tablets.
    Spireas S; Sadu S; Grover R
    J Pharm Sci; 1998 Jul; 87(7):867-72. PubMed ID: 9649356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Ceolus KG-802 on the dissolution rate of fenofibrate liquisolid tablets: Preformulation and formulation development studies.
    Karmarkar AB
    Drug Discov Ther; 2010 Dec; 4(6):493-8. PubMed ID: 22491315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developing in vitro-in vivo correlation of risperidone immediate release tablet.
    Saibi Y; Sato H; Tachiki H
    AAPS PharmSciTech; 2012 Sep; 13(3):890-5. PubMed ID: 22696224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Liquisolid technique for enhancement of dissolution prosperities of tanshinone II(A)].
    Liu XQ; Meng QJ; Xu XL; Zhao J; Yang H; Yi H
    Zhongguo Zhong Yao Za Zhi; 2015 Dec; 40(24):4840-6. PubMed ID: 27245032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissolution enhancement of tadalafil by liquisolid technique.
    Lu M; Xing H; Yang T; Yu J; Yang Z; Sun Y; Ding P
    Pharm Dev Technol; 2017 Feb; 22(1):77-89. PubMed ID: 27268461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Technical Approach of Solubility Enhancement of Poorly Soluble Drugs: Liquisolid Technique.
    Chaudhary N; Tripathi D; Rai AK
    Curr Drug Deliv; 2020; 17(8):638-650. PubMed ID: 32416691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
    Sawant KK; Patel MH; Patel K
    Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melt dispersion granules: formulation and evaluation to improve oral delivery of poorly soluble drugs - a case study with valsartan.
    Chella N; Tadikonda R
    Drug Dev Ind Pharm; 2015 Jun; 41(6):888-97. PubMed ID: 24796274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upgrading of dissolution and anti-hypertensive effect of Carvedilol via two combined approaches: self-emulsification and liquisolid techniques.
    Ibrahim TM; Abdallah MH; El-Megrab NA; El-Nahas HM
    Drug Dev Ind Pharm; 2018 Jun; 44(6):873-885. PubMed ID: 29254384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liquigroud technique: a new concept for enhancing dissolution rate of glibenclamide by combination of liquisolid and co-grinding technologies.
    Azharshekoufeh L; Shokri J; Barzegar-Jalali M; Javadzadeh Y
    Bioimpacts; 2017; 7(1):5-12. PubMed ID: 28546948
    [No Abstract]   [Full Text] [Related]  

  • 38. Novel electrosprayed nanospherules for enhanced aqueous solubility and oral bioavailability of poorly water-soluble fenofibrate.
    Yousaf AM; Mustapha O; Kim DW; Kim DS; Kim KS; Jin SG; Yong CS; Youn YS; Oh YK; Kim JO; Choi HG
    Int J Nanomedicine; 2016; 11():213-21. PubMed ID: 26834471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and characterization of liquisolid compacts for improved dissolution of telmisartan.
    Chella N; Narra N; Rama Rao T
    J Drug Deliv; 2014; 2014():692793. PubMed ID: 25371826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro profiling of fenofibrate solid dispersion mediated tablet formulation to treat high blood cholesterol.
    Atneriya U; Kapoor D; Sainy J; Maheshwari R
    Ann Pharm Fr; 2023 Mar; 81(2):284-299. PubMed ID: 36037932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.